当前位置: 首页 > 期刊 > 《上海医药》 > 2013年第1期 > 正文
编号:12335163
Pim—1激酶小分子抑制剂的研究进展(6)
http://www.100md.com 2013年1月1日 孙占莉 肖旭华 袁博
第1页
第5页

    参见附件。

     [29] Sliman F, Blairvacq M, Durieu E, et al. Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase[J]. Bioorg Med Chem Lett, 2010, 20(9): 2801-2805.

    [30] Miduturu CV, Deng X, Kwiatkowski N, et al. High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors[J]. Chem Biol, 2011, 18(7): 868-879.

    [31] Xiang YB, Hirth B, Asmussen G, et al. The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors[J]. Bioorg Med Chem Lett, 2011, 21(10): 3050-3056.

    [32] Anizon F, Shtil AA, Danilenko VN, et al. Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors[J]. Curr Med Chem, 2010, 17(34): 4114-4133.

    [33] Tsuganezawa K, Watanabe H, Parker L, et al. A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide[J]. J Mol Biol, 2012, 417(3): 240-252.

    [34] Sarno S, Mazzorana M, Traynor R, et al. Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A[J]. Cell Mol Life Sci, 2012, 69(3): 449-460.

    (收稿日期:2012-09-13)

    

您现在查看是摘要介绍页,详见PDF附件(5209kb)